Eden Research (LON:EDEN) Stock Price Down 3.3% – What’s Next?

Eden Research plc (LON:EDEN)’s stock price traded down 3.3% on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares were traded during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The firm has a market cap of £18.56 million, a PE ratio of -12.19 and a beta of 0.92. The company’s fifty day moving average price is GBX 3.88 and its two-hundred day moving average price is GBX 3.95. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26.

Insider Buying and Selling

In related news, insider Lykele van der Broek acquired 256,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 6th. The shares were purchased at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Also, insider Alexander John Abrey acquired 540,540 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). 14.02% of the stock is owned by insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.